연구동향 분석

Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis

신동금 정보영 조익성 Briain o Hartaigh 문희선 이혜영 황의석 박진규 엄재선 박희남 이문형 2015년

논문상세정보
인용/피인용
' Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • atrial fibrillation
  • cardiovascularevents
  • cardioversion
  • safety
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,144 1

0.0%

' Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis' 의 참고문헌

  • “Cardioversion”of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients
    Lown B N Engl J Med 269 : 325 ~ 331 [1963]
  • “Cardioversion”of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients
    Lown B N Engl J Med 269 325-331 [1963]
  • Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
    Roy D Am Heart J 112 : 1039 ~ 1043 [1986]
  • Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
    Roy D Am Heart J 112 1039-1043 [1986]
  • Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
    Klein AL N Engl J Med 344 : 1411 ~ 1420 [2001]
  • Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
    Klein AL N Engl J Med 344 1411-1420 [2001]
  • Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study
    Airaksinen KE J Am Coll Cardiol 62 : 1187 ~ 1192 [2013]
  • Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study
    Airaksinen KE J Am Coll Cardiol 62 1187-1192 [2013]
  • The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
    Bjerkelund CJ Am J Cardiol 23 : 208 ~ 216 [1969]
  • The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
    Bjerkelund CJ Am J Cardiol 23 208-216 [1969]
  • Termination of ventricular fibrillation in man by externally applied electric countershock
    Zoll PM N Engl J Med 254 : 727 ~ 732 [1956]
  • Termination of ventricular fibrillation in man by externally applied electric countershock
    Zoll PM N Engl J Med 254 727-732 [1956]
  • Safety of electrical cardioversion in patients with atrial fibrillation
    Gentile F Mayo Clin Proc 77 : 897 ~ 904 [2002]
  • Safety of electrical cardioversion in patients with atrial fibrillation
    Gentile F Mayo Clin Proc 77 897-904 [2002]
  • Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
    Arnold AZ J Am Coll Cardiol 19 : 851 ~ 855 [1992]
  • Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
    Arnold AZ J Am Coll Cardiol 19 851-855 [1992]
  • Outpatient electrical cardioversion of atrial fibrillation:8 years’ experience. Analysis of shock-related arrhythmias
    Morani G Pacing Clin Electrophysiol 32 : 1152 ~ 1158 [2009]
  • Outpatient electrical cardioversion of atrial fibrillation:8 years’ experience. Analysis of shock-related arrhythmias
    Morani G Pacing Clin Electrophysiol 32 1152-1158 [2009]
  • Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs
    Botkin SB Am Heart J 145 : 233 ~ 238 [2003]
  • Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs
    Botkin SB Am Heart J 145 233-238 [2003]
  • Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation:a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group
    Yamaguchi T Stroke 31 : 817 ~ 821 [2000]
  • Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation:a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group
    Yamaguchi T Stroke 31 817-821 [2000]
  • New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge
    Lown B JAMA 182 : 548 ~ 555 [1962]
  • New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge
    Lown B JAMA 182 548-555 [1962]
  • Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
    American College of Cardiology Foundation Circulation 127 : 1916 ~ 1926 [2013]
  • Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
    American College of Cardiology Foundation Circulation 127 1916-1926 [2013]
  • Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation
    Suzuki S Circ J 71 : 761 ~ 765 [2007]
  • Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation
    Suzuki S Circ J 71 761-765 [2007]
  • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    European Heart Rhythm Association Europace 12 : 1360 ~ 1420 [2010]
  • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    European Heart Rhythm Association Europace 12 1360-1420 [2010]
  • Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version
    JCS Joint Working Group Circ J 74 : 2479 ~ 2500 [2010]
  • Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version
    JCS Joint Working Group Circ J 74 2479-2500 [2010]
  • External electrical termination of supraventricular arrhythmias in congenital heart disease
    Paul MH Circulation 25 : 604 ~ 609 [1962]
  • External electrical termination of supraventricular arrhythmias in congenital heart disease
    Paul MH Circulation 25 604-609 [1962]
  • Epidemiologic features of chronic atrial fibrillation: the Framingham study
    Kannel WB N Engl J Med 306 : 1018 ~ 1022 [1982]
  • Epidemiologic features of chronic atrial fibrillation: the Framingham study
    Kannel WB N Engl J Med 306 1018-1022 [1982]
  • Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients
    Jensen JB JAMA : 1181 ~ 1184 [1965]
  • Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients
    Jensen JB JAMA 194 1181-1184 [1965]
  • Dabigatran versus warfarin in patients with atrial fibrillation:an analysis of patients undergoing cardioversion
    Nagarakanti R Circulation 123 : 131 ~ 136 [2011]
  • Dabigatran versus warfarin in patients with atrial fibrillation:an analysis of patients undergoing cardioversion
    Nagarakanti R Circulation 123 131-136 [2011]
  • Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion
    Resnekov L Br Heart J 29 : 926 ~ 936 [1967]
  • Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion
    Resnekov L Br Heart J 29 926-936 [1967]
  • Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation:the Euro Heart Survey
    Pisters R Europace 14 : 666 ~ 674 [2012]
  • Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation:the Euro Heart Survey
    Pisters R Europace 14 666-674 [2012]
  • Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study
    Wolf PA Arch Intern Med 147 : 1561 ~ 1564 [1987]
  • Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study
    Wolf PA Arch Intern Med 147 1561-1564 [1987]
  • Atrial fibrillation and stroke: new ideas, persisting dilemmas
    Halperin JL Stroke 19 : 937 ~ 941 [1988]
  • Atrial fibrillation and stroke: new ideas, persisting dilemmas
    Halperin JL Stroke 19 937-941 [1988]
  • Arrhythmic complications of electrical cardioversion: relationship to shock energy
    Gallagher MM Int J Cardiol 123 : 307 ~ 312 [2008]
  • Arrhythmic complications of electrical cardioversion: relationship to shock energy
    Gallagher MM Int J Cardiol 123 307-312 [2008]
  • Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study
    Grönberg T Europace 15 : 1432 ~ 1435 [2013]
  • Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study
    Grönberg T Europace 15 1432-1435 [2013]
  • Anticoagulation for cardioversion of atrial fibrillation
    Weinberg DM Am J Cardiol 63 : 745 ~ 746 [1989]
  • Anticoagulation for cardioversion of atrial fibrillation
    Weinberg DM Am J Cardiol 63 745-746 [1989]
  • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society
    January CT Circulation 130 2071-2104 [2014]
  • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
    January CT Circulation 130 : 2071 ~ 2104 [2014]